Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
3
×
texas top stories
wisconsin blog main
wisconsin top stories
aduro biotech
alzheimer's disease
biogen
celgene
clinical trials
deals
drug prices
gene therapy
johnson & johnson
What
bio
companies
3
×
roundup
drug
price
alzheimer’s
approval
arena’s
biogen’s
biopharmaceutical
bounty
cig
comeback
convo
corner
deals
delivered
different
earlier
expressing
fail
failures
gene
increases
ipo
latest
life
littered
little
moderna’s
nash
new
news
number
pharmaceutical
plan
prescription
prices
raise
remains
Language
Current search:
medicare
×
companies
×
" texas blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
